|

68Ga-FAPI Clinical Trials

2 actively recruiting trials

▼ -1 trial since July 2026

Also known as: 68Ga-FAPI injection, 68Ga-Fibroblast activation protein Inhibitor, 68Ga-fibroblast activation protein inhibitor

Pipeline

Phase 1/2: 1

Top Sponsors

  • Zhongnan Hospital1
  • Peking Union Medical College Hospital1

Indications

  • Sjogren's Syndrome1
  • Fibroblast Activation Protein Inhibitor1
  • Arthritis1
  • Malignant Neoplasm1
  • PET-CT1

Other2 trials

68Ga-FAPI PET/CT in Malignant Tumors
N/A
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.